Patent_application_number,Applicant_name,Year_of_application,Patent_system
WO1990004028A1,KANEKA CORP,1990,WIPO
WO1993001328A1,LUDWIG INSTITUTE FOR CANCER RESEARCH,1993,WIPO
WO1995003426A2,BIO MERIEUX (FR),1995,WIPO
WO1995008627A1,NOVARTIS,1995,WIPO
WO1995009245A1,ASS POUR LE DEV DE LA RECH (FR),1995,WIPO
WO1996005492A1,NOVARTIS,1996,WIPO
WO1997002696A1,MEDICAL RESEARCH COUNCIL,1997,WIPO
WO1997006918A1,CANCER RESEARCH UK,1997,WIPO
WO1998000027A2,YLAE HERTTUALA SEPPO (FI); MARTIN JOHN FRANCIS (GB),1998,WIPO
WO1998001327A1,FOURNIER ALAIN (FR); MERKEN LUC (FR),1998,WIPO
WO1998004810A1,BOGAERT THIERRY ANDRE OLIVIER (BE); DERAEYMAEKER MARC (BE),1998,WIPO
WO1998007848A1,ASKA PHARMACEUTICAL,1998,WIPO
WO1998008068A1,WAGENINGEN UNIVERSOTY,1998,WIPO
WO1998008418A1,JENKINS OWEN (GB); BEELEY LEE JAMES (GB),1998,WIPO
WO1998009275A1,APPLIGENE ONCOR S A (FR); OZANNE VALERIE (FR),1998,WIPO
WO1998037187A1,TAKARA HOLDINGS,1998,WIPO
WO1998056926A1,TAKARA HOLDINGS,1998,WIPO
WO1999001260A1,MAX PLANCK SOCIETY,1999,WIPO
WO1999001780A1,BIRCHMEIER WALTER (DE); BEHRENS JUERGEN (DE),1999,WIPO
WO1999003791A1,DIERL STEFAN (DE); RUETERJANS HEINZ (DE),1999,WIPO
WO1999004322A1,SERLUPI CRESCENZI OTTAVIANO (IT); DELLA PIETRA LINDA (IT),1999,WIPO
WO1999005271A1,CAMPOS GOMEZ JAVIER,1999,WIPO
WO1999006052A1,BARBEYRON TRISTAN (FR); GOEMAR LAB SA (FR); FLAMENT DIDIER (FR); KLOAREG BERNARD (FR); POTIN PHILIPPE (FR); YVIN JEAN CLAUDE (FR),1999,WIPO
WO1999008639A1,TODD DANIEL (GB); WESTON JONATHAN (GB); AKZO NOBEL NV (NL),1999,WIPO
WO1999009837A1,EUROP LAB MOLEKULARBIOLOG (DE); ZHANG YOUMING (DE),1999,WIPO
WO1999011797A1,TAKARA HOLDINGS,1999,WIPO
WO1999027117A1,TAKARA HOLDINGS,1999,WIPO
WO2000000086A1,ENTERPRISE IRELAND (BIORESEARCH IRELAND),2000,WIPO
WO2000001796A2,HEISIG PETER (DE); MERLIN GES FUER MIKROBIOLOGISC (DE); FUCHS GOMEZ YOLANDA (US),2000,WIPO
WO2000003091A1,SCUDDER KURT MARSHALL (DK); THERMO FISHER SCIENTIFIC,2000,WIPO
WO2000005192A2,LUIS BERNHARD,2000,WIPO
WO2000005324A1,ARCH DEVELOPMENT CORPORATION (US),2000,WIPO
WO2000005361A1,"SCHACKERT, HANS KONRAD (DE); HAHN, MATTHIAS (DE)",2000,WIPO
WO2000039288A1,TAKARA HOLDINGS,2000,WIPO
WO2001000030A1,CNRS,2001,WIPO
WO2001000147A1,OREGON STATE (US),2001,WIPO
WO2001000337A1,HOLOGIC INC,2001,WIPO
WO2001000999A1,EBARA CORPORATION,2001,WIPO
WO2001001024A1,UNIVERSITY OF CALIFORNIA,2001,WIPO
WO2001001356A1,CNRS,2001,WIPO
WO2001001614A1,CHEMICO INTERNATIONAL INC,2001,WIPO
WO2001001813A1,GENECOPOEIA,2001,WIPO
WO2001002211A1,UNIVERSITY OF CALIFORNIA,2001,WIPO
WO2001002300A1,INSTITUT PASTEUR,2001,WIPO
WO2001002471A1,CELLDEX,2001,WIPO
WO2001002567A1,MEDIGENE AG (DE),2001,WIPO
WO2001002887A1,AGILENT TECHNOLOGIES,2001,WIPO
WO2001002900A1,ACGT PROGENOMICS,2001,WIPO
WO2001002919A1,VERTEX PHARMACEUTICALS,2001,WIPO
WO2001002942A2,LUDWIG INSTITUTE FOR CANCER RESEARCH,2001,WIPO
WO2001003494A1,UNIVERSITY OF CALIFORNIA,2001,WIPO
WO2001003583A1,ROCHE DIAGNOSTICS,2001,WIPO
WO2001003604A2,"BECTON, DICKINSON AND COMPANY",2001,WIPO
WO2001004447A1,GOVERNMENT OF CHINA,2001,WIPO
WO2001004536A1,BIOSYN ARZNEIMITTEL GMBH (DE),2001,WIPO
WO2001005664A2,PRINCETON UNIVERSITY,2001,WIPO
WO2001005773A1,PRINCETON UNIVERSITY,2001,WIPO
WO2001005971A2,"PHYCOGEN, INC. (US)",2001,WIPO
WO2001006382A1,PROKAZYME,2001,WIPO
WO2001007144A2,ACTIVE BIOTECH AB,2001,WIPO
WO2001007150A2,TAKARA HOLDINGS,2001,WIPO
WO2001007242A1,VERTEX PHARMACEUTICALS,2001,WIPO
WO2001007580A1,PROMEGA CORPORATION,2001,WIPO
WO2001007855A1,"DELTAGEN, INC. (US)",2001,WIPO
WO2001008186A1,INSTITUT PASTEUR,2001,WIPO
WO2001008338A2,THERMO FISHER SCIENTIFIC,2001,WIPO
WO2001008824A1,PROLUME LTD,2001,WIPO
WO2001008829A1,ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US); THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US),2001,WIPO
WO2001008865A1,AQUA HEALTH (EUROPE) LIMITED (GB),2001,WIPO
WO2001009091A1,"METABOLIX, INC. (US)",2001,WIPO
WO2001009128A1,BASF,2001,WIPO
WO2001009296A1,BAYER,2001,WIPO
WO2001009347A2,AGILENT TECHNOLOGIES,2001,WIPO
WO2001009348A1,TAKARA HOLDINGS,2001,WIPO
WO2001009458A1,NOVOZYMES,2001,WIPO
WO2001009464A1,NOVOZYMES,2001,WIPO
WO2001009712A1,AKZO NOBEL N.V. (NL),2001,WIPO
WO2002000182A2,AQUABIO PRODUCTS,2002,WIPO
WO2002000215A1,AQUABIO PRODUCTS,2002,WIPO
WO2002000735A1,BASF,2002,WIPO
WO2002000811A2,BASF,2002,WIPO
WO2002000965A1,TAKARA HOLDINGS,2002,WIPO
WO2002001144A1,MAX PLANCK SOCIETY,2002,WIPO
WO2002001149A2,AQUABIO PRODUCTS,2002,WIPO
WO2002001157A1,NORWEGIAN INST OF FISHERIES & (NO),2002,WIPO
WO2002002459A1,BAYER,2002,WIPO
WO2002002469A1,BAYER,2002,WIPO
WO2002002470A1,BAYER,2002,WIPO
WO2002002508A1,BAYER,2002,WIPO
WO2002003072A2,THERMO FISHER SCIENTIFIC,2002,WIPO
WO2002004361A1,ASTELLAS PHARMA INC ,2002,WIPO
WO2002004739A1,UNIVERSITY OF CALIFORNIA,2002,WIPO
WO2002006458A2,CHEMICO INTERNATIONAL INC,2002,WIPO
WO2002006601A1,"OMNIGENE BIOPRODUCTS, INC. (US)",2002,WIPO
WO2002006784A1,AKZO NOBEL N.V. (NL),2002,WIPO
WO2002006944A1,PROMEGA CORPORATION,2002,WIPO
WO2002006946A1,BIORIGINAL FOOD & SCIENCE CORP. (CA),2002,WIPO
WO2002007529A2,GOVERNMENT OF CHINA,2002,WIPO
WO2002008343A2,"DELTAGEN, INC. (US)",2002,WIPO
WO2002008401A2,ABBOTT LABORATORIES,2002,WIPO